Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving arm and hand recovery after spinal cord injury using therapy and stimulation

Official title: Feasibility and Efficacy of Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation for Neurorestoration of Upper Limbs After Cervical Spinal Cord Injury

Run by University Health Network, Toronto · NCT06472986 · Data updated 2026-11-12

This study is testing if combining special therapy with spinal cord stimulation can help people with cervical spinal cord injuries recover better use of their arms and hands.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedOctober 7, 2022
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJuly 9, 2024
Trial IDNCT06472986 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with chronic cervical spinal cord injuries who are neurologically stable and have specific motor function scores.

Probably not a fit

Patients with other upper extremity deficits or severe spasticity limiting motion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ABT-TCSCS study evaluates the feasibility and effectiveness of combining activity-based therapy with transcutaneous spinal cord stimulation to enhance recovery of arm and hand function in individuals with cervical spinal cord injuries. This one-arm interventional study will involve up to 24 participants who will undergo a structured rehabilitation program consisting of 12 sessions of activity-based therapy followed by 28 sessions of combined therapy and stimulation. Assessments will be conducted at various stages to monitor neurological stability and functional improvements.

Why it matters

Potential benefit: If successful, this approach could significantly improve upper limb function and quality of life for patients with cervical spinal cord injuries.

How similar studies have gone: While the combination of activity-based therapy and spinal cord stimulation is promising, this specific approach is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals with chronic traumatic and non-traumatic cervical SCI (ASIA classification A-incomplete\*\*, B, C, D) between C1-C8
* Adults more than 18 years old
* At least 6 months post-spinal cord injury
* A score of 2 - 15 on the upper extremity motor score of the ISNCSCI
* A score between 5 - 40 on GRASSP Version 1 Strength on at least one side
* Individuals who are medically stable

Exclusion Criteria:

* Individuals with any other upper extremity deficit
* Unable to provide informed consent
* Unable to participate in an intensive rehabilitation outpatient program
* Spasticity that limits the range of motion greater than 50% for the elbow or wrist

Where it's running

  • Toronto Rehabilitation Institute
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Sukhvinder Kalsi-Ryan — Toronto Rehabilitation Institute
  • Study coordinator: Urvashy Gopaul, PhD
  • Email: urvashy.gopaul@uhn.ca
  • Phone: 416-597-3422

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.